According to the Centers for Disease Control and Prevention (CDC), chronic and mental health conditions account for approximately 86% of healthcare spending in the U.S.
By 2025, chronic diseases could affect nearly half of the U.S. population. Many people with chronic conditions are elderly and some have mobility limitations. Chronic conditions typically require frequent visits to physicians.
Telehealth On The Rise?
COVID-19 changed healthcare significantly as providers were forced to find new ways to treat patients without risking infection with the virus. This seemingly drove telehealth into mainstream healthcare during the pandemic, and its use remains reportedly strong today.
Telehealth also is an option for treating mental health and substance use disorders.
Data Bridge Market Research reports the telehealth market in North America is growing at a compound annual growth rate (CAGR) of 10% for the forecast period of 2022 to 2029 and is expected to reach $22.4 trillion by 2029, up from $10.4 trillion in 2021.
Major players in the telehealth market include Teladoc Health Inc. TDOC, Medtronic plc MDT and American Well Corp. AMWL, which provide telehealth technology products and sponsor academic research.
Cloud DX Inc. CDX is one such telehealth platform provider that says it wants to assert its place as a key partner in the telehealth industry through the products and services it brings to and enables in the telemedicine market.
Remote Patient Monitoring (RPM)
One area of telehealth that has seen particularly big gains in the past two years according to some experts, is remote patient monitoring (RPM). RPM uses technology to gather key vital signs, such as weight, blood pressure, pulse oximetry, or temperature, from patients at home daily. Clinicians can monitor these vitals from almost anywhere and look for patterns that could indicate a patient’s health is improving or declining.
RPM relies heavily on telemedicine devices such as wearable electrocardiograms, blood pressure and blood glucose monitors, biosensors, digital medical scopes and accessories, and wearable activity trackers, including FitBits and smartwatches.
Cloud DX says its Connected Health™ kit and platform has all the components for RPM to keep patients connected and help providers work more efficiently.
According to the company, its hardware can integrate seamlessly with patients’ electronic medical records (EMRs), enabling providers to quickly compare test results, review patient history, and make thorough assessments without flipping through paper records.
What Is In The Connected Health Kit?
The Cloud DX platform and its Connected Health™ kit is a “modern version of a doctor’s bag”. It contains a set of gadgets that the company states collectively support physicians in making accurate diagnoses of patient conditions. It can contain:
- Custom Android Health Tablet
- Pulsewave wrist cuff blood pressure monitor
- Wireless Bluetooth scale
- Wireless pulse oximeter
- Glucose monitor
The kit enables a patient to speak instantly to a licensed clinician by text or video and allows both patient and clinician to track vital signs on an ongoing basis with easy-to-use Food and Drug Administration (FDA)-cleared devices.
The online clinician can also see a patient's vitals in real-time during a consultation and make diagnoses.
The kit has curated health content and feed customizable to individual patients’ medical conditions. A patient’s full medical history can be accessed on the Cloud DX patient portal using the application (via tablet or personal smart device), or by the physician through the Clinician Portal
Cloud DX keeps up with the latest innovations in telemedicine technology integrating artificial intelligence (AI) to analyze patient data to help providers work more efficiently while keeping patients connected with wearables and other tools for Remote Patient Monitoring. The company also reports developing an augmented reality platform for RPM for the Medical Metaverse through its Cloud XR divisions (Cloud eXtended Reality).
To learn more about Cloud DX and its products click here.
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Featured photo by Markus Winkler on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.